CBSA Pres/CEO Holli Riebel interviewed with 9News yesterday regarding the new federal law that cuts the FDA's approval timetable for new drugs. Quoting from the 9News posting:
"Supporters say the bill would benefit hundreds of Colorado startups that are developing novel medicines and therapies.
They say the provision could also help severely ill patients who are willing to take experimental drugs that haven't undergone the full battery of tests for all possible side effects and complications...
...About 600 bioscience companies, research institutions and venture capital groups in Colorado employ about 20,000 people, and the industry continues to grow despite the sluggish economy, according to the Colorado Bioscience Association."
Link to the video report or view here: